Ace Cardiopathy Solutions Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 2.98 M
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 34.65 Cr
- Satisfied Charges ₹ 15.70 Cr
- Revenue Growth 4.55%
- Profit Growth -29.85%
- Ebitda -7.40%
- Net Worth 51.65%
- Total Assets 26.77%
About Ace Cardiopathy Solutions
Ace Cardiopathy Solutions Private Limited (ACSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 December 2009 and has a history of 15 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 2.98 M.
The company currently has active open charges totaling ₹34.65 Cr. The company has closed loans amounting to ₹15.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Umesh Munjal and Gaurav Manocha serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2009PTC196486
- Company No.
196486
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Ace Cardiopathy Solutions Private Limited offer?
Ace Cardiopathy Solutions Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, CPAP Mask, CPAP, BiPAP Machine & Accessories.
Who are the key members and board of directors at Ace Cardiopathy Solutions?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Umesh Munjal ![]() | Director | 01-Dec-2009 | Current |
Gaurav Manocha ![]() | Director | 10-Jul-2012 | Current |
Financial Performance of Ace Cardiopathy Solutions.
Ace Cardiopathy Solutions Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.55% increase. The company also saw a substantial fall in profitability, with a 29.85% decrease in profit. The company's net worth Soared by an impressive increase of 51.65%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ace Cardiopathy Solutions?
In 2024, Ace Cardiopathy Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹346.52 M
₹156.96 M
Charges Breakdown by Lending Institutions
- Others : 23.73 Cr
- Standard Chartered Bank : 7.95 Cr
- Hdfc Bank Limited : 1.94 Cr
- Axis Bank Limited : 1.03 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
28 Mar 2024 | Others | ₹2.50 M | Open |
09 Aug 2023 | Axis Bank Limited | ₹1.03 Cr | Open |
16 May 2023 | Standard Chartered Bank | ₹4.50 M | Open |
02 Feb 2023 | Hdfc Bank Limited | ₹3.51 M | Open |
07 Oct 2022 | Hdfc Bank Limited | ₹3.00 M | Open |
How Many Employees Work at Ace Cardiopathy Solutions?
Ace Cardiopathy Solutions has a workforce of 67 employees as of Jan 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ace Cardiopathy Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ace Cardiopathy Solutions's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.